Position in ALT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$615,235
+$559,407 QoQ
Shares Held
202,380
+1016.5% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 210 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALT Over Time
Shares Held
Position Value (USD)
Derivatives in ALT
reported options exposure · as of Mar 31, 2023CallValue
$112,252
CallShares
26,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. ALT ranks #135 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in ALT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $615,235 | 202,380 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $55,828 | 18,126 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $126,165 | 34,949 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,204,303 | 584,696 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $669,425 | 133,885 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $106,030 | 14,706 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $378,764 | 61,688 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $134,152 | 13,178 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,268,696 | 112,773 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $493,885 | 139,911 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $904,194 | 214,264 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $112,252 | 26,600 | Call | Defined | 2023-05-15 | |
| 2022-06-30 | $329,156 | 28,133 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $576,278 | 94,627 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $131,729 | 14,381 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $685,476 | 60,608 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $101,967 | 10,352 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $269,636 | 20,427 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||